Latest news
Loading news…
CardiaLen develops and commercializes pain-free cardioversion therapies for atrial fibrillation.
CardiaLen was acquired by Maxwell Biomedical in 2022.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
8
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Minneapolis, Minnesota, United States
Key People at CardiaLen
VP Development
CEO and President
8
professional contacts at CardiaLen
Contact execs at CardiaLen →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to CardiaLen
Loading news…
FAQs about CardiaLen
People who checked this page also checked these
Browse the full Acquirezy directory.